GO:1990454 L-type voltage-gated calcium channel complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990454 describes the L-type voltage-gated calcium channel complex, a high-voltage-activated calcium channel responsible for long-lasting calcium influx and excitation-contraction coupling in skeletal, smooth, and cardiac muscle.
• The complex is a hetero-oligomer built from a pore-forming CaV1 alpha-1 subunit (CaV1.1-CaV1.4) plus auxiliary beta, alpha-2/delta, and gamma subunits that tune trafficking, gating, and pharmacology.
• L-type channels are not just ion conduits; they act as signaling scaffolds that couple to calcium-release channels, kinases, and adaptor proteins such as Ahnak and p11/Anxa2.
• Dysregulation of the complex is linked to cardiac arrhythmia, bipolar disorder, depression-like behavior, tuberous sclerosis complex, and Alzheimer's disease.
• Assembly of the channel is assisted by ER-resident chaperones such as the EMC complex, which stabilizes an ion-channel assembly intermediate.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect subunit-specific contributions to channel function and disease.
Description
The L-type voltage-gated calcium channel complex (GO:1990454) is a multi-subunit plasma-membrane assembly that mediates long-lasting calcium entry in response to membrane depolarization. It is the principal calcium channel responsible for excitation-contraction coupling in skeletal, smooth, and cardiac muscle, and it also shapes neuronal excitability, gene expression, and hormone secretion. Because calcium is a universal second messenger, the activity of this complex is tightly coupled to downstream signaling pathways, including calcium-release channels and calcium-dependent enzymes. Researchers study GO:1990454 to understand how subunit composition, auxiliary proteins, and chaperones determine channel trafficking, gating, and pharmacology. The complex is also a validated drug target: dihydropyridines and other L-type channel blockers are used clinically for hypertension and angina, while channelopathies cause cardiac arrhythmia and neurological disease. In the nervous system, L-type channels in dendrites contribute to synaptic plasticity and are implicated in mood disorders and neurodegenerative conditions. This article summarizes the authoritative QuickGO definition, the structural and functional organization of the complex, the genes involved, disease links, and the CRISPR-based methods used to study it.
L-type voltage-gated calcium channel complex At A Glance
| GO ID | GO:1990454 |
|---|---|
| GO term | L-type voltage-gated calcium channel complex |
| Ontology | cellular_component |
| Synonym | cardiac muscle L-type voltage-gated calcium channel complex; skeletal muscle L-type voltage-gated calcium channel complex |
| Major function | Long-lasting voltage-dependent calcium influx mediating excitation-contraction coupling in muscle and calcium signaling in neurons |
| Core subunits | Pore-forming CaV1 alpha-1 subunit plus beta, alpha-2/delta, and gamma auxiliary subunits |
| Ion selectivity | Highly selective for calcium ions; activated by strong membrane depolarization |
| Tissue distribution | Skeletal muscle, cardiac muscle, smooth muscle, and neurons |
| Assembly chaperone | ER membrane protein complex (EMC) assists assembly of the channel |
What Is GO:1990454?
GO:1990454 describes a type of voltage-dependent calcium channel complex that produces long-lasting calcium currents and is responsible for excitation-contraction coupling in skeletal, smooth, and cardiac muscle. The 'L' stands for long-lasting, referring to the prolonged activation of the channel after depolarization. The complex is a heteromeric assembly of a pore-forming alpha-1 subunit with auxiliary beta, alpha-2/delta, and gamma subunits, and it is localized to the plasma membrane where it opens in response to strong depolarization.
Why Is L-type voltage-gated calcium channel complex Important in Cell Biology?
The L-type voltage-gated calcium channel complex is a central node in calcium signaling because it converts electrical depolarization into a chemical calcium signal that drives muscle contraction, secretion, and gene expression. Its dysfunction is directly linked to human disease, including cardiac arrhythmia, bipolar disorder, depression-like behavior, tuberous sclerosis complex, and Alzheimer's disease. Because the complex is a validated drug target, understanding its subunit composition and regulation is essential for pharmacology and for interpreting disease-associated variants.
• Mediates excitation-contraction coupling in skeletal, smooth, and cardiac muscle.
• Provides the primary route for calcium entry that activates calcium-release channels in muscle.
• Shapes neuronal excitability, dendritic calcium signaling, and synaptic plasticity.
• Is a validated target of dihydropyridine drugs used for cardiovascular disease.
• Dysfunction is linked to bipolar disorder and depression-like behavior through scaffold proteins such as Ahnak and p11/Anxa2.
• Reduced dendritic L-type channel activity is observed in tuberous sclerosis complex and Alzheimer's disease models.
• Assembly depends on ER chaperones such as the EMC complex, linking channel biogenesis to ER quality control.
• Auxiliary subunits modulate trafficking, gating, and pharmacology, making them attractive research targets.
• Retinoschisin regulates L-type channel function, connecting the complex to retinal physiology.
• CRISPR models enable causal testing of subunit genes in disease-relevant cell types.
L-type voltage-gated calcium channel complex: biological process, structure, and molecular mechanism
Depolarization-induced channel activation
In simple terms: When a muscle or nerve cell is stimulated, the voltage across its membrane changes, and the L-type channel opens to let calcium in.
The L-type voltage-gated calcium channel complex is activated by strong membrane depolarization, which drives the pore-forming alpha-1 subunit into an open conformation and allows calcium to flow into the cell. This long-lasting calcium current is the defining physiological signature of L-type channels and is responsible for excitation-contraction coupling in skeletal, smooth, and cardiac muscle. The channel's voltage-sensing domains move in response to the membrane potential, coupling electrical excitation to calcium entry.
Excitation-contraction coupling
In simple terms: The calcium that enters through the L-type channel tells the muscle cell to contract.
In cardiac and skeletal muscle, calcium entry through the L-type channel triggers calcium release from the sarcoplasmic reticulum through ryanodine receptors, a process known as calcium-induced calcium release. This amplification step is essential for the force and timing of muscle contraction, and it depends on the close physical coupling between the L-type channel complex and intracellular calcium-release channels. In smooth muscle, L-type channel activity sustains tonic calcium entry that maintains vascular tone.
Calcium-dependent signaling and gene expression
In simple terms: Calcium entering through the channel also acts as a messenger that can change which genes are turned on.
Beyond contraction, calcium entering through L-type channels activates calcium-dependent enzymes and transcription factors, linking membrane excitation to long-term changes in gene expression. In neurons, dendritic L-type channels contribute to calcium signals that underlie synaptic plasticity and behavior, and their hypoactivity has been linked to disease states. The channel complex therefore functions as a signaling hub, not merely an ion pore.
Scaffolding and protein-protein interactions
In simple terms: The channel is part of a larger machine, held together by adaptor proteins that connect it to other signaling molecules.
The L-type channel complex interacts with scaffold and adaptor proteins that anchor it to signaling microdomains. Ahnak scaffolds the p11/Anxa2 complex and the L-type voltage-gated calcium channel, and this interaction modulates depressive behavior. Retinoschisin facilitates the function of L-type voltage-gated calcium channels, indicating that extracellular and membrane-associated proteins can regulate channel activity. These interactions expand the functional repertoire of the complex beyond ion conduction.
Assembly and ER quality control
In simple terms: Before the channel reaches the cell surface, it must be assembled correctly inside the cell with the help of chaperones.
Biogenesis of the L-type channel complex requires assembly of the pore-forming alpha-1 subunit with auxiliary subunits in the endoplasmic reticulum. The ER membrane protein complex (EMC) acts as a chaperone that stabilizes an ion-channel assembly intermediate, revealing how the cell monitors and assists channel folding. This assembly step is critical because misfolded or misassembled channels are retained in the ER and degraded.
Key Genes Involved in GO:1990454 L-type voltage-gated calcium channel complex
The L-type voltage-gated calcium channel complex is encoded by a family of CACNA genes plus auxiliary subunit genes and interacting proteins that together determine channel function and regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CACNA1C | Pore-forming alpha-1 subunit of CaV1.2, the main cardiac and neuronal L-type channel | Central to cardiac arrhythmia, bipolar disorder, and calcium signaling research |
| CACNA1S | Pore-forming alpha-1 subunit of CaV1.1 in skeletal muscle | Mediates skeletal muscle excitation-contraction coupling |
| CACNA1D | Pore-forming alpha-1 subunit of CaV1.3 in neurons and endocrine cells | Contributes to neuronal calcium signaling and hormone secretion |
| CACNA1F | Pore-forming alpha-1 subunit of CaV1.4 in retina | Linked to retinal physiology and L-type channel function |
| CACNB1 | Beta auxiliary subunit that modulates trafficking and gating | Determines channel surface expression and pharmacology |
| CACNB2 | Beta auxiliary subunit in heart and brain | Modulates cardiac L-type current and disease risk |
| CACNA2D1 | Alpha-2/delta auxiliary subunit | Regulates channel trafficking and drug binding |
| CACNG1 | Gamma auxiliary subunit in skeletal muscle | Modulates skeletal muscle channel properties |
| AHNAK | Scaffold protein that links p11/Anxa2 to the L-type channel | Modulates depressive behavior and channel function |
| S100A10 (p11) | Annexin A2 light chain that scaffolds with Ahnak | Part of the Ahnak-p11/Anxa2 complex regulating L-type channels |
| ANXA2 | Annexin A2, a calcium-dependent membrane-binding protein | Forms a complex with p11 and Ahnak to regulate L-type channels |
| RS1 | Retinoschisin, an extracellular protein | Facilitates L-type voltage-gated calcium channel function |
| PARK7 (DJ-1) | Redox-sensitive protein linked to L-type channel hypoactivity | Aberrant DJ-1 expression underlies L-type channel hypoactivity in dendrites |
| EMC1 | Subunit of the ER membrane protein complex | Chaperone assisting ion-channel assembly |
| EMC2 | Subunit of the ER membrane protein complex | Chaperone assisting ion-channel assembly |
| EMC3 | Subunit of the ER membrane protein complex | Chaperone assisting ion-channel assembly |
| RYR1 | Ryanodine receptor 1, calcium-release channel in skeletal muscle | Functional partner in excitation-contraction coupling |
| RYR2 | Ryanodine receptor 2, calcium-release channel in cardiac muscle | Functional partner in calcium-induced calcium release |
How Is L-type voltage-gated calcium channel complex Regulated?
The L-type voltage-gated calcium channel complex is regulated at multiple levels. Auxiliary beta, alpha-2/delta, and gamma subunits modulate trafficking, voltage dependence, and pharmacology of the pore-forming alpha-1 subunit. Scaffold proteins such as Ahnak, p11, and Anxa2 anchor the channel to signaling complexes and modulate its activity in the context of depressive behavior. Extracellular factors such as retinoschisin can facilitate channel function, indicating that the channel is responsive to its local environment. In disease states, altered expression of DJ-1 is associated with L-type channel hypoactivity in dendrites, linking redox regulation to channel function. Assembly of the complex is regulated by ER chaperones such as the EMC complex, which stabilizes an assembly intermediate and ensures quality control.
L-type voltage-gated calcium channel complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CACNA1C | Bipolar disorder, cardiac arrhythmia, calcium signaling | Knockout or point-mutation iPSC-derived cardiomyocytes and neurons |
| AHNAK | Depression-like behavior, channel scaffolding | Knockout mouse and neuronal cell lines |
| PARK7 (DJ-1) | Tuberous sclerosis complex, Alzheimer's disease, dendritic channel hypoactivity | Knockdown or overexpression in neurons |
| RS1 | Retinal physiology, L-type channel facilitation | Knockout or knock-in retinal cell models |
| CACNB2 | Cardiac arrhythmia, L-type current modulation | Knockout or point-mutation cardiomyocytes |
Cardiac and skeletal muscle channelopathies
Because the L-type channel complex mediates excitation-contraction coupling, mutations or dysregulation of its subunits can cause cardiac arrhythmia and skeletal muscle dysfunction. The cardiac L-type channel macromolecular complex is a well-studied target in cardiovascular pharmacology, and its auxiliary subunits influence disease susceptibility. Understanding the complex is therefore essential for interpreting genetic variants in CACNA1C, CACNB2, and related genes.
Bipolar disorder and depression
The L-type voltage-gated calcium channel complex has been implicated in the neurobiology of bipolar disorder, where calcium signaling genes are among the most consistently associated risk factors. Ahnak scaffolds the p11/Anxa2 complex and the L-type channel, and this interaction modulates depressive behavior, providing a mechanistic link between the channel and mood regulation. These findings support the study of L-type channel complexes in psychiatric disease models.
Tuberous sclerosis complex and Alzheimer's disease
Aberrant DJ-1 expression underlies L-type calcium channel hypoactivity in dendrites in tuberous sclerosis complex and Alzheimer's disease, suggesting that the complex is functionally impaired in these conditions. This dendritic channel hypoactivity may contribute to synaptic dysfunction, making the L-type complex a potential target for further investigation in neurodegeneration.
Retinal and sensory dysfunction
Retinoschisin facilitates the function of L-type voltage-gated calcium channels, linking the complex to retinal physiology. This interaction suggests that L-type channel regulation is relevant to sensory function and may be altered in retinal disease.
From L-type voltage-gated calcium channel complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CACNA1C abolish L-type calcium current? | CRISPR knockout in cardiomyocytes or neurons |
| Does a disease-associated point mutation alter channel gating? | CRISPR point mutation knock-in in cell lines |
| Does tagging the alpha-1 subunit affect channel trafficking? | CRISPR knock-in of fluorescent or epitope tag |
| Does overexpression of Ahnak change channel activity? | CRISPR overexpression or cDNA overexpression in neurons |
| Does loss of EMC subunits impair channel assembly? | CRISPR knockout of EMC genes followed by biochemical analysis |
| Does retinoschisin regulate L-type channel function? | Knockout or overexpression in retinal cells |
How to Study the L-type voltage-gated calcium channel complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion current amplitude, voltage dependence, kinetics | Functional validation of channel subunits and mutants |
| Calcium imaging | Intracellular calcium transients | Measuring channel activity in live cells |
| Co-immunoprecipitation | Protein-protein interactions and subunit composition | Mapping the channel macromolecular complex |
| Blue native PAGE | Assembly state of multi-subunit complexes | Testing chaperone dependence of channel assembly |
| RNA sequencing | Transcriptional changes downstream of channel activity | Identifying calcium-regulated gene programs |
| CRISPR knockout screening | Gene requirement for channel function or expression | Discovering novel regulators of L-type channels |
| Immunofluorescence microscopy | Subcellular localization of channel subunits | Assessing trafficking and dendritic localization |
| Western blotting | Protein expression levels of channel subunits | Validating knockout or overexpression efficiency |
Patch-clamp electrophysiology
Patch-clamp recording is the gold-standard method to measure L-type calcium currents directly, including voltage dependence, inactivation kinetics, and pharmacology. It can be applied to cells after CRISPR knockout or knock-in to test the functional consequences of specific mutations.
Calcium imaging
Calcium imaging with fluorescent indicators measures intracellular calcium transients and can report L-type channel activity in living cells. This method is useful for assessing dendritic calcium signals and excitation-contraction coupling in muscle cells.
Biochemical complex analysis
Co-immunoprecipitation and blue native PAGE can resolve the subunit composition and assembly state of the L-type channel complex. These approaches are essential for testing whether auxiliary subunits or chaperones such as EMC are required for assembly.
CRISPR-based genetic screens and transcriptomics
CRISPR knockout screens combined with RNA sequencing can identify genes that regulate L-type channel expression or function. Transcriptomic profiling of cells with channel mutations reveals downstream calcium-dependent gene expression changes.
How CRISPR Can Be Used to Study GO:1990454 L-type voltage-gated calcium channel complex
Knockout
CRISPR knockout of CACNA1C, CACNA1S, or auxiliary subunit genes eliminates specific components of the L-type voltage-gated calcium channel complex, allowing researchers to test which subunits are required for calcium current, excitation-contraction coupling, and downstream signaling. Knockout of scaffold proteins such as Ahnak can reveal their role in channel modulation and behavior.
Point Mutation
CRISPR point mutation introduces disease-associated missense variants into channel genes to test their effects on gating, trafficking, and pharmacology. This approach is valuable for interpreting variants identified in cardiac arrhythmia and neurological disorders.
Knock-in
CRISPR knock-in can add fluorescent or epitope tags to endogenous channel subunits, enabling real-time tracking of channel trafficking and assembly. Knock-in of reporter cassettes can also be used to monitor channel expression in specific cell types.
Overexpression
CRISPR overexpression or cDNA-based overexpression of channel subunits and interacting proteins such as Ahnak or retinoschisin can test gain-of-function effects on L-type channel activity. Overexpression models are useful for studying calcium-dependent signaling and disease mechanisms.
How EDITGENE Supports L-type voltage-gated calcium channel complex Research
Researchers studying L-type voltage-gated calcium channel complex-related genes often need to determine whether a candidate gene is causally involved in channel function, calcium signaling, or disease. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for L-type voltage-gated calcium channel complex research.
Frequently Asked Questions About L-type voltage-gated calcium channel complex
What is GO:1990454?
GO:1990454 is the Gene Ontology term for the L-type voltage-gated calcium channel complex, a multi-subunit calcium channel responsible for long-lasting calcium influx and excitation-contraction coupling in muscle.
What is the L-type voltage-gated calcium channel complex?
It is a heteromeric plasma-membrane channel composed of a pore-forming CaV1 alpha-1 subunit and auxiliary beta, alpha-2/delta, and gamma subunits that mediates long-lasting calcium currents.
What genes are involved in the L-type voltage-gated calcium channel complex?
Key genes include CACNA1C, CACNA1S, CACNA1D, CACNA1F, CACNB1, CACNB2, CACNA2D1, and CACNG1, as well as interacting proteins such as AHNAK and RS1.
What does 'L-type' mean in calcium channels?
The 'L' stands for long-lasting, referring to the prolonged activation of the channel after membrane depolarization.
Where is the L-type voltage-gated calcium channel complex found?
It is found in the plasma membrane of skeletal, smooth, and cardiac muscle cells and in neurons, where it mediates calcium entry.
What diseases are linked to L-type calcium channel dysfunction?
Dysfunction has been linked to cardiac arrhythmia, bipolar disorder, depression-like behavior, tuberous sclerosis complex, and Alzheimer's disease.
How is the L-type calcium channel complex regulated?
It is regulated by auxiliary subunits, scaffold proteins such as Ahnak and p11/Anxa2, extracellular factors such as retinoschisin, and ER chaperones such as the EMC complex.
What is the role of the EMC complex in L-type channel assembly?
The ER membrane protein complex acts as a chaperone that stabilizes an ion-channel assembly intermediate, assisting proper folding and assembly of the channel.
How can CRISPR be used to study L-type calcium channels?
CRISPR knockout, point mutation, knock-in, and overexpression can be used to test the causal role of channel subunits and interacting proteins in calcium signaling and disease.
What methods are used to measure L-type calcium channel activity?
Patch-clamp electrophysiology, calcium imaging, co-immunoprecipitation, and RNA sequencing are commonly used to measure channel function and downstream effects.
Conclusion
The L-type voltage-gated calcium channel complex (GO:1990454) is a central calcium-signaling machine that couples membrane depolarization to muscle contraction, neuronal plasticity, and gene expression. Its multi-subunit architecture, auxiliary protein interactions, and chaperone-assisted assembly make it a rich subject for mechanistic and disease-focused research. Dysregulation of the complex is implicated in cardiovascular, psychiatric, and neurodegenerative disorders, underscoring its clinical importance. CRISPR-based models provide a powerful way to dissect the causal contributions of individual subunits and interacting proteins, and EDITGENE offers comprehensive services to support such studies.
References
- 1. Harrison PJ et al.. 2018. The Emerging Neurobiology of Bipolar Disorder.. Trends Neurosci 41(1):18-30 PMID: 29169634
- 2. Catterall W et al.. 1992. Ion channels.. Diabetologia 35 Suppl 2:S23-33 PMID: 1282478
- 3. Jin J et al.. 2020. Ahnak scaffolds p11/Anxa2 complex and L-type voltage-gated calcium channel and modulates depressive behavior.. Mol Psychiatry 25(5):1035-1049 PMID: 30760886
- 4. Rougier JS et al.. 2016. Cardiac voltage-gated calcium channel macromolecular complexes.. Biochim Biophys Acta 1863(7 Pt B):1806-12 PMID: 26707467
- 5. Wu J et al.. 2017. Structure-Function Relationship of the Voltage-Gated Calcium Channel Ca(v)1.1 Complex.. Adv Exp Med Biol 981:23-39 PMID: 29594856
- 6. Niere F et al.. 2023. Aberrant DJ-1 expression underlies L-type calcium channel hypoactivity in dendrites in tuberous sclerosis complex and Alzheimer's disease.. Proc Natl Acad Sci U S A 120(45):e2301534120 PMID: 37903257
- 7. Shi L et al.. 2017. Retinoschisin Facilitates the Function of L-Type Voltage-Gated Calcium Channels.. Front Cell Neurosci 11:232 PMID: 28848397
- 8. Chen Z et al.. 2023. EMC chaperone-Ca(V) structure reveals an ion channel assembly intermediate.. Nature 619(7969):410-419 PMID: 37196677
